Cannabidiol as a treatment for post-traumatic stress disorder among Canadian Veterans: a pilot clinical trial

大麻二酚治疗加拿大退伍军人创伤后应激障碍：一项试点临床试验

• 批准号: 441582
• 负责人: Shield Kevin D
• 金额: --
• 依托单位: Centre for Addiction and Mental Health (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-11-01 至 2021-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=441582&lang=en
• 关键词: Cannabidiol; Cannabis; Gender; Post-Traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a highly disabling condition, associated with panic attacks, troubled relationships, unemployment, and suicide. Yet, current treatments for PTSD are only fully effective in approximately 50% of patients. Preliminar

创伤后应激障碍（PTSD）是一种高度致残的疾病，与恐慌发作、关系紧张、失业和自杀有关。然而，目前的PTSD治疗方法仅对约50%的患者完全有效。布雷萨尔